IL113480A - Benzocycloalkyl-azolethione derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Benzocycloalkyl-azolethione derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL113480A
IL113480A IL11348095A IL11348095A IL113480A IL 113480 A IL113480 A IL 113480A IL 11348095 A IL11348095 A IL 11348095A IL 11348095 A IL11348095 A IL 11348095A IL 113480 A IL113480 A IL 113480A
Authority
IL
Israel
Prior art keywords
azolethione
benzocycloalkyl
thioxo
dihydro
derivatives
Prior art date
Application number
IL11348095A
Other languages
English (en)
Other versions
IL113480A0 (en
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27398461&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL113480(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/233,655 external-priority patent/US5438150A/en
Priority claimed from US08/403,209 external-priority patent/US5538988A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Priority to IL12556198A priority Critical patent/IL125561A0/xx
Priority to IL12556195A priority patent/IL125561A/xx
Publication of IL113480A0 publication Critical patent/IL113480A0/xx
Publication of IL113480A publication Critical patent/IL113480A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
IL11348095A 1994-04-26 1995-04-25 Benzocycloalkyl-azolethione derivatives their preparation and pharmaceutical compositions containing them IL113480A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL12556198A IL125561A0 (en) 1994-04-26 1995-04-25 (s)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-ylamine and its preparation
IL12556195A IL125561A (en) 1994-04-26 1995-04-25 (S)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-ylamine and the preparation of a S-enantiomer of 1,2,3,4-tetrahydronaphthalen-2-ylamine derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23383594A 1994-04-26 1994-04-26
US08/233,655 US5438150A (en) 1994-04-26 1994-04-26 Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives
US08/403,209 US5538988A (en) 1994-04-26 1995-03-17 Benzocycloalkylazolethione derivatives

Publications (2)

Publication Number Publication Date
IL113480A0 IL113480A0 (en) 1995-07-31
IL113480A true IL113480A (en) 2000-06-29

Family

ID=27398461

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11348095A IL113480A (en) 1994-04-26 1995-04-25 Benzocycloalkyl-azolethione derivatives their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
EP (1) EP0757677B1 (zh)
JP (1) JPH09512269A (zh)
CN (1) CN1113874C (zh)
AT (1) ATE243199T1 (zh)
AU (1) AU687192B2 (zh)
BR (1) BR9507517A (zh)
CA (1) CA2188748A1 (zh)
CZ (1) CZ290082B6 (zh)
DE (1) DE69531102T2 (zh)
DK (1) DK0757677T3 (zh)
ES (1) ES2201104T3 (zh)
FI (1) FI964312A (zh)
HU (1) HUT76295A (zh)
IL (1) IL113480A (zh)
MX (1) MX9605145A (zh)
NO (1) NO311720B1 (zh)
NZ (1) NZ284356A (zh)
PL (1) PL185959B1 (zh)
PT (1) PT757677E (zh)
RU (1) RU2145321C1 (zh)
WO (1) WO1995029165A2 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2201944B1 (en) 1997-11-21 2012-05-23 Purdue Neuroscience Company Use of substituted 2-aminoacetamides for treating, preventing or ameliorating manic depression
AU2298399A (en) * 1998-02-06 1999-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Novel azapeptide type hydroxamic acid derivatives
JP4978762B2 (ja) * 2001-03-30 2012-07-18 Ｄｉｃ株式会社 シクロヘキサ−３−エン−１−オール誘導体の製造方法
GB2393958A (en) * 2002-10-11 2004-04-14 Portela & Ca Sa Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
GB0600709D0 (en) * 2006-01-13 2006-02-22 Portela & Ca Sa Drug combinations
RU2009126571A (ru) 2006-12-12 2011-01-20 Биал-Портела Энд Ка, С.А. (Pt) Каталитический способ асимметричной гидрогенизации
US20100093817A1 (en) * 2007-02-01 2010-04-15 Bial - Portela & Ca S.A. Compounds
EP1977646A1 (en) * 2007-04-03 2008-10-08 Bayer CropScience AG Insecticidal hydroxyethyl thlourea derivatives
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
GB0709695D0 (en) * 2007-05-21 2007-06-27 Portela & Ca Sa Process
TW200927740A (en) * 2007-11-13 2009-07-01 Bial Portela & Ca Sa Process
EP2726454B1 (en) 2011-06-29 2018-01-24 Bial-Portela & CA, S.A. Process
TR201815850T4 (tr) * 2012-11-14 2018-11-21 Bial Portela & Ca Sa Pulmoner arteryel hipertansiyonun ve akciğer hasarının tedavisinde kullanım için 1,3-dihidroimidazol-2-tion türevleri.
EP3490554B1 (en) * 2016-07-28 2023-07-05 Jiangsu Yahong Meditech Co., Ltd. Uses of dopamine beta-hydroxylase (dbh) inhibitors for the treatment of cancer
JOP20190050A1 (ar) 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز تخترق حاجز المخ الدموي
US11434242B2 (en) 2017-12-04 2022-09-06 Bial—Portela & Ca, S.A. Dopamine-b-hydroxylase inhibitors
GB201908044D0 (en) 2019-06-05 2019-07-17 Bial Portela & Ca Sa Dopamine-B-Hydroxylase inhibitors
MX2023008573A (es) 2021-01-26 2023-08-08 Jiangsu Yahong Meditech Co Ltd Modulador de via, composicion farmaceutica que tiene la misma, uso y metodo terapeutico que utiliza la misma.
CN113527108B (zh) * 2021-09-16 2022-10-25 斯芬克司药物研发（天津）股份有限公司 一种制备光学纯的5,7-二氟-1,2,3,4-四氢化萘-2-胺及其盐的方法
CN114920906B (zh) * 2022-05-23 2023-03-21 华南理工大学 一种含咪唑硫酮单元的聚氨酯及其制备方法和应用
WO2024056079A1 (zh) * 2022-09-16 2024-03-21 江苏亚虹医药科技股份有限公司 内匹司他酸加成盐的多晶型及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485917A (en) * 1966-04-14 1969-12-23 Janssen Pharmaceutica Nv Composition and method for combating fungus with imidazole carboxylates
GB8516573D0 (en) * 1985-07-01 1985-08-07 Janssen Pharmaceuticaa Nv Controlling weeds
EP0277384A3 (en) * 1986-12-24 1990-05-23 Janssen Pharmaceutica N.V. 1h-imidazole-5-carboxylic acid derivatives

Also Published As

Publication number Publication date
WO1995029165A3 (en) 1995-12-07
MX9605145A (es) 1997-12-31
NO311720B1 (no) 2002-01-14
RU2145321C1 (ru) 2000-02-10
HUT76295A (en) 1997-07-28
DE69531102D1 (de) 2003-07-24
FI964312A (fi) 1996-12-20
BR9507517A (pt) 1997-09-16
DK0757677T3 (da) 2003-10-13
FI964312A0 (fi) 1996-10-25
AU2294795A (en) 1995-11-16
WO1995029165A2 (en) 1995-11-02
NO964552D0 (no) 1996-10-25
PL316856A1 (en) 1997-02-17
PT757677E (pt) 2003-11-28
ES2201104T3 (es) 2004-03-16
CZ290082B6 (cs) 2002-05-15
NZ284356A (en) 1997-12-19
EP0757677A1 (en) 1997-02-12
DE69531102T2 (de) 2004-04-29
PL185959B1 (pl) 2003-09-30
CZ310996A3 (en) 1997-06-11
JPH09512269A (ja) 1997-12-09
CN1113874C (zh) 2003-07-09
CN1151735A (zh) 1997-06-11
HU9602946D0 (en) 1996-12-30
ATE243199T1 (de) 2003-07-15
CA2188748A1 (en) 1995-11-02
AU687192B2 (en) 1998-02-19
IL113480A0 (en) 1995-07-31
EP0757677B1 (en) 2003-06-18
NO964552L (no) 1996-12-27

Similar Documents

Publication Publication Date Title
IL113480A (en) Benzocycloalkyl-azolethione derivatives their preparation and pharmaceutical compositions containing them
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
DE69705300T2 (de) Cyclopropylalkansäurederivate
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
HU9600299D0 (en) Substituted azadioxacycloalkenes, fungicidal compositions containing them, process for the preparation of the compounds and the fungicidal compositions and method for combating fungi
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
ES2150489T3 (es) 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas.
MX9701538A (es) Sales de un derivado del indol contra la migraña.
MY136249A (en) Phenylethanolamine compounds as anti-obesity agents
GEP20043362B (en) Novel $G(Y)Crystalline Form of Perindopril Tert- Butylamine Salt, Preparation Method, and Pharmaceutical Compositions Containing Same
GEP20043360B (en) Novel $G(Beta Crystalline Form of Perindopril Tert-Butylamine Salt, Preparation Method, and Pharmaceutical Compositions Containing Same
CO5070569A1 (es) Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen
UA27108A1 (uk) Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя
CA2444071A1 (en) Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
AU5090393A (en) Platelet aggregation inhibitors
MX9805023A (es) Derivados de 1-metilcarbapenem.
DE69530123D1 (en) Plättchenaggregationsinhibitoren
NZ240441A (en) Thiazol- or thiadiazol-substituted 7-acyl-3-substituted carbamoyloxy cephem derivatives and antibacterial compositions thereof; cephem intermediates
ZA935045B (en) Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives
WO2000024389A3 (en) Benzoquinoline derivatives useful as antibacterial agents
NZ290236A (en) Inhibition ofleucotriene biosynthesis and pharmaceutical compositions comprising aryl-urea derivatives
ES8605819A1 (es) Procedimiento de preparacion de nuevos derivados nucleosidos.
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees